Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 0.33 |
| ▸ | DRD4 | P21917 | 8/20 | 0.33 |
| ▸ | DRD3 | P35462 | 8/20 | 0.33 |
| ▸ | DRD1 | P21728 | 6/20 | 0.33 |
| ▸ | DRD5 | P21918 | 6/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HTR5A | P47898 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2225881 | 0.90 | KMT2A (0.30) | KMT2A | |
| SCHEMBL4624493 | 0.88 | DRD2 (0.32) | DRD2DRD4DRD3DRD1DRD5 | |
| Trifluoromethanesulfonic Acid SCHEMBL29065751 | 0.88 | MAPT (0.32) | KMT2AMAPK1MAPT | |
| SCHEMBL4532049 | 0.85 | HDAC4 (0.37) | KMT2AMAPK1MAPT | |
| SCHEMBL5705543 | 0.82 | DRD2 (0.39) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL7787043 | 0.81 | DRD2 (0.38) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL8438875 | 0.80 | P2RX7 (0.30) | — | |
| SCHEMBL1602668 | 0.78 | DRD2 (0.31) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL1603303 | 0.78 | DRD2 (0.31) | DRD2DRD4DRD3DRD1DRD5 | |
| SCHEMBL4802829 | 0.77 | DRD2 (0.35) | DRD2DRD4DRD3DRD1DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590976-B2 | Detection method using both fluorescence and chemiluminescence labels | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2026-03-31 | — | — | US | disclosed |
| US-12416627-B2 | Immunoassay with enhanced sensitivity | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2025-09-16 | — | — | US | disclosed |
| US-20240302386-A1 | DETECTION METHOD USING BOTH FLUORESCENCE AND CHEMILUMINESCENCE LABELS | ACCESS MEDICAL SYSTEMS, LTD. | 2024-09-12 | — | — | US | disclosed |
| US-20240272153-A1 | METHOD FOR RE-USING A TEST SOLID SURFACE IN A BIOCHEMICAL ASSAY | ACCESS MEDICAL SYSTEMS LTD (US) | 2024-08-15 | — | — | US | disclosed |
| CN-118076895-A | Method for testing solid surface repeatedly in biochemical determination | 万迈医疗仪器有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-116648458-A | Detection methods using both fluorescent and chemiluminescent labels | 万迈医疗仪器有限公司 | 2023-08-25 | — | — | CN | disclosed |
| US-20210041428-A1 | IMMUNOASSAY WITH ENHANCED SENSITIVITY | ACCESS MEDICAL SYSTEMS, LTD. | 2021-02-11 | — | — | US | disclosed |
| US-10809251-B2 | Immunoassay with enhanced sensitivity | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2020-10-20 | — | — | US | disclosed |
| US-10718764-B2 | Electrochemiluminescent detection system | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2020-07-21 | — | — | US | disclosed |
| US-10451616-B2 | Wide range luminescent immunoassays | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2019-10-22 | — | — | US | disclosed |
| US-20170052178-A1 | ELECTROCHEMILUMINESCENT DETECTION SYSTEM | ACCESS MEDICAL SYSTEMS LTD (US) | 2017-02-23 | — | — | US | disclosed |
| US-9568431-B2 | Luminescent immunoassays for quantitating analytes having a wide concentration range | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2017-02-14 | — | — | US | disclosed |
| US-9435794-B2 | Luminescent polymer cyclic amplification | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2016-09-06 | — | — | US | disclosed |
| US-20150276724-A1 | LUMINESCENT POLYMER CYCLIC AMPLIFICATION | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2015-10-01 | — | — | US | disclosed |
| EP-2699906-A2 | LUMINESCENT POLYMER CYCLIC AMPLIFICATION | Access Medical Systems, Ltd. (US) | 2014-02-26 | — | — | EP | disclosed |
| US-8647889-B2 | Luminescent polymer cyclic amplification | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2014-02-11 | — | — | US | disclosed |
| US-20130273667-A1 | WIDE RANGE LUMINESCENT IMMUNOASSAYS | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2013-10-17 | — | — | US | disclosed |
| US-20130071952-A1 | LUMINESCENT POLYMER CYCLIC AMPLIFICATION | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2013-03-21 | — | — | US | disclosed |
| WO-2012145270-A2 | LUMINESCENT POLYMER CYCLIC AMPLIFICATION | ACCESS MEDICAL SYSTEMS, LTD. (US) | 2012-10-26 | — | — | WO | disclosed |
| US-20120231459-A1 | CHEMILUMINESCENT PROBES FOR MULTIPLEX MOLECULAR QUANTIFICATION AND USES THEREOF | GEN-PROBE INCORPORATED (US) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590976-B2 | Detection method using both fluorescence and chemiluminescence labels | CD14, FLT4, FLT1 | DRD2 3491/4885DRD4 2791/4885DRD3 2926/4885 |
| US-20120231459-A1 | CHEMILUMINESCENT PROBES FOR MULTIPLEX MOLECULAR QUANTIFICATION AND USES THEREOF | HMBS, NOD1, DCLRE1B | DRD2 2584/4885DRD4 1741/4885DRD3 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.